Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 1
1988 2
1993 1
1999 1
2003 1
2004 4
2005 2
2006 1
2007 1
2008 2
2009 4
2010 2
2011 2
2012 3
2013 4
2014 3
2015 5
2016 4
2017 4
2018 3
2019 2
2020 5
2021 5
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Results by year
Filters applied: . Clear all The following terms were ignored: %, %, % The following terms were not found in PubMed: 20DL, 5BAuthor
Page 1
Specific exercises for subacromial pain.
Björnsson Hallgren HC, Adolfsson LE, Johansson K, Öberg B, Peterson A, Holmgren TM. Björnsson Hallgren HC, et al. Acta Orthop. 2017 Dec;88(6):600-605. doi: 10.1080/17453674.2017.1364069. Epub 2017 Aug 16. Acta Orthop. 2017. PMID: 28812398 Free PMC article. Clinical Trial.
The 1-year assessment included Constant-Murley score, DASH, VAS at night, rest and activity, EQ-5D, and EQ-VAS. All these outcome assessments were repeated after 5 years in 91 of the patients. ...
The 1-year assessment included Constant-Murley score, DASH, VAS at night, rest and activity, EQ-5D, and EQ-VAS. All these outcome ass …
The effect of massage therapy and/or exercise therapy on subacute or long-lasting neck pain--the Stockholm neck trial (STONE): study protocol for a randomized controlled trial.
Skillgate E, Bill AS, Côté P, Viklund P, Peterson A, Holm LW. Skillgate E, et al. Trials. 2015 Sep 16;16:414. doi: 10.1186/s13063-015-0926-4. Trials. 2015. PMID: 26377322 Free PMC article. Clinical Trial.
The secondary outcomes are global improvement, health-related quality of life (EQ-5D), sick leave, drug consumption and healthcare utilization. Adverse events are measured by questionnaires at return visits to the clinic, and automated text messages (SMSes) survey neck pai …
The secondary outcomes are global improvement, health-related quality of life (EQ-5D), sick leave, drug consumption and healthcare ut …
Measuring the Change in Health-Related Quality of Life in Patients Using Marijuana for Pain Relief.
Peterson AM, Le C, Dautrich T. Peterson AM, et al. Med Cannabis Cannabinoids. 2021 Aug 12;4(2):114-120. doi: 10.1159/000517857. eCollection 2021 Winter. Med Cannabis Cannabinoids. 2021. PMID: 35224431 Free PMC article.
Recruited subjects completed 4 surveys - at enrollment (baseline) then 2, 4, and 8 weeks post-enrollment. We used the EQ-5D survey tool for measuring HRQoL. The primary outcome measure was the change in the EQ-5D Index Score from survey 2 to survey 4 (6 week differe …
Recruited subjects completed 4 surveys - at enrollment (baseline) then 2, 4, and 8 weeks post-enrollment. We used the EQ-5D survey to …
Modifying Metastable Sr1-xBO3-δ (B = Nb, Ta, and Mo) Perovskites for Electrode Materials.
Ofoegbuna T, Peterson B, da Silva Moura N, Nepal R, Kizilkaya O, Smith C, Jin R, Plaisance C, Flake JC, Dorman JA. Ofoegbuna T, et al. ACS Appl Mater Interfaces. 2021 Jun 16;13(25):29788-97. doi: 10.1021/acsami.1c05743. Online ahead of print. ACS Appl Mater Interfaces. 2021. PMID: 34133135 Free PMC article.
The presence of surface/deep defects in 4d- and 5d-perovskite oxide (ABO(3), B = Nb, Ta, Mo, etc.) nanoparticles (NPs), originating from multivalent B-site cations, contributes to suppressing their metallic properties. ...
The presence of surface/deep defects in 4d- and 5d-perovskite oxide (ABO(3), B = Nb, Ta, Mo, etc.) nanoparticles (NPs), originating f …
Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS.
Amin AP, Wang TY, McCoy L, Bach RG, Effron MB, Peterson ED, Cohen DJ. Amin AP, et al. J Am Coll Cardiol. 2016 Jan 5;67(1):59-65. doi: 10.1016/j.jacc.2015.10.034. J Am Coll Cardiol. 2016. PMID: 26764067 Free PMC article.
Those who experienced any BARC bleeding had lower scores across all 5 EQ-5D domains (mobility, self-care, usual activities, pain, and anxiety), as well as lower EQ-5D VAS and EQ-5D index scores. After clinical risk adjustment, any BARC bleeding was independen …
Those who experienced any BARC bleeding had lower scores across all 5 EQ-5D domains (mobility, self-care, usual activities, pain, and …
The effect of intravenous golimumab on health-related quality of life and work productivity in patients with active psoriatic arthritis: results of the Phase 3 GO-VIBRANT trial.
Ogdie A, Walsh JA, Chakravarty SD, Peterson S, Lo KH, Kim L, Li N, Hsia EC, Chan EKH, Kavanaugh A, Husni ME. Ogdie A, et al. Clin Rheumatol. 2021 Sep;40(9):3667-3677. doi: 10.1007/s10067-021-05639-1. Epub 2021 Mar 2. Clin Rheumatol. 2021. PMID: 33655380 Free PMC article. Clinical Trial.
Relationships between these outcomes and disease activity and patient functional capability were evaluated post hoc. RESULTS: At Week 8, change from baseline in EQ-5D-5L index (0.14 vs 0.04), EQ-VAS (17.16 vs 3.69), daily productivity VAS (-2.91 vs -0.71), and WLQ producti …
Relationships between these outcomes and disease activity and patient functional capability were evaluated post hoc. RESULTS: At Week 8, cha …
The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial.
Reveille JD, Hwang MC, Danve A, Kafka S, Peterson S, Lo KH, Kim L, Hsia EC, Chan EKH, Deodhar A. Reveille JD, et al. Clin Rheumatol. 2021 Apr;40(4):1331-1341. doi: 10.1007/s10067-020-05342-7. Epub 2020 Sep 14. Clin Rheumatol. 2021. PMID: 32926247 Clinical Trial.
RESULTS: At week 16, changes from baseline (mean standard deviation) in EQ-5D-5L index (0.17 0.16 vs 0.05 0.14), EQ-VAS (20.3 24.6 vs 4.8 23.5), daily productivity VAS (- 2.9 - 2.9 vs - 1.1 - 2.5), WLQ productivity loss score (- 3.5 - 5.3 vs - 1.9 - 4.0), and ASQoL (- 5.4 …
RESULTS: At week 16, changes from baseline (mean standard deviation) in EQ-5D-5L index (0.17 0.16 vs 0.05 0.14), EQ-VAS (20.3 24.6 vs …
Sex differences in quality of life after ischemic stroke.
Bushnell CD, Reeves MJ, Zhao X, Pan W, Prvu-Bettger J, Zimmer L, Olson D, Peterson E. Bushnell CD, et al. Neurology. 2014 Mar 18;82(11):922-31. doi: 10.1212/WNL.0000000000000208. Epub 2014 Feb 7. Neurology. 2014. PMID: 24510493 Free PMC article.
METHODS: We assessed QOL in patients with ischemic stroke or TIA at 3 and 12 months postdischarge in the Adherence eValuation After Ischemic stroke-Longitudinal Registry using the European Quality of Life-5 Dimensions (EQ-5D) instrument. We generated multivariable linear r …
METHODS: We assessed QOL in patients with ischemic stroke or TIA at 3 and 12 months postdischarge in the Adherence eValuation After Ischemic …
56 results